LifeStance Health Group, Inc.·4

Jul 7, 7:41 PM ET

Bessler Robert 4

Research Summary

AI-generated summary

Updated

LifeStance (LFST) Director Robert Bessler Receives RSU Award

What Happened

  • Robert Bessler, a director of LifeStance Health Group, Inc. (LFST), was granted 17,746 restricted stock units (RSUs) on 2026-07-02. The grant is reported at $0 (no cash exchanged on grant). Each RSU represents a contingent right to one share of common stock and will convert to shares only if vesting conditions are met.

Key Details

  • Transaction type: Award/Grant (code A) of 17,746 RSUs.
  • Transaction date: 2026-07-02; Form 4 filed: 2026-07-07.
  • Price: $0.00 per unit as reported; total reported consideration $0.
  • Shares owned after transaction: not specified in the filing.
  • Notable filings/footnotes:
    • F1: Confirms each RSU converts to one share upon vesting.
    • F2–F4: The reporting person disclaims beneficial ownership except to the extent of pecuniary interest; some shares are held of record by Alpine Glow Capital, of which the reporting person is manager and sole member.
  • Filing timeliness: The Form 4 was filed five days after the transaction date; Form 4s are typically due within two business days under Section 16, so this may be a late filing.

Context

  • RSU grants are compensation awards that vest over time or upon meeting conditions; they are not immediate purchases or sales and do not necessarily signal near-term trading intent.
  • Because the securities are contingent RSUs and the filer disclaims beneficial ownership beyond pecuniary interest (and holds certain shares through Alpine Glow Capital), this report primarily documents a compensation grant rather than an outright change in beneficial ownership.